4th Quarter - Report

WALTER CONSULTING for AMERISOURCEBERGEN CORPORATION

Period 4th Quarter 2011 Filed Jan 20, 2012 Signed by Sarah Walter, President

Official filing
Firm
WALTER CONSULTING
Client
AMERISOURCEBERGEN CORPORATION
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

ASP Generally (in the context of Deficit Reduction) Pharmaceutical Distribution Reimbursement H.R.905/S.733-- Excluding customary prompt pay discounts from ASP Pharmaceutical pedigree anti-counterfeiting legislation-- H.R. 1483, H.R. 3026 & S. 1584 Drug shortage issue

LobbyistCovered position, as disclosed
SARAH WALTER Former Legislative Director, Sen. John Breaux

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3026 (112th), H.R. 905 (112th), S. 733 (112th), S. 1584 (112th), H.R. 1483 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.